Navigation Links
Sequenom to Webcast Analyst and Investor Briefing Presentation on June 3
Date:5/28/2008

SAN DIEGO, May 28 /PRNewswire-FirstCall/ -- Sequenom, Inc. (Nasdaq: SQNM) today announced that a live audio webcast and accompanying slide presentation will be provided for its analyst and investor briefing event "Sequenom: The Future of Noninvasive Prenatal Diagnostics." Details of the event are as follows:

What: Sequenom: The Future of Noninvasive Prenatal Diagnostics

When: Tuesday, June 3, 2008 at 6:00 p.m. Pacific time

Where: http://www.sequenom.com

Agenda:

Hosted by:

Harry Stylli, Ph.D., Chief Executive Officer of Sequenom, Inc.

Presenters:

Jacob Canick, Ph.D., Professor of Pathology and Laboratory Medicine

Brown University Medical School

"Methods for screening pregnancies for Down syndrome"

Allan T. Bombard, MD, FACOG, FACS, FACMG, Chief Medical Officer, Sharp

Mary Birch Hospital; Adjunct Professor, Obstetrics and Gynecology/SUNY

Downstate Medical Center; Clinical Professor, Albert Einstein College of

Medicine

"Current clinical practice for Down syndrome screening and diagnosis"

Betty Dragon, Ph.D., Senior Vice President, Research & Development of

Sequenom, Inc.

"Sequenom's SEQureDx: A noninvasive prenatal diagnostic test for Down

syndrome. Technical Achievements, Milestones and Future Challenges"

Dennis Lo, Consultant to Sequenom, Inc.

"The future of prenatal diagnosis: Progress through fetal nucleic acids"

How: Live over the Internet - Simply log on to the web at the address

above. Presentation will be archived.

Contact: Lippert/Heilshorn & Associates

Jody Cain (jcain@lhai.com)

310-691-7100

About Sequenom

Sequenom is committed to providing the best genetic analysis products for research and the molecular diagnostic markets. The Company m
'/>"/>

SOURCE Sequenom, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Sequenom to Webcast Analyst and Investor Briefing Presentation on September 24
2. REMINDER: Exelixis Will Webcast Its June 2 Investor and Analyst Briefing at ASCO
3. Exelixis Announces June 2 Webcast of Its ASCO Investor and Analyst Briefing
4. CorVel Corporation Announces Earnings Release Webcast
5. Forest Laboratories, Inc. and Laboratorios Almirall, S.A. to Host Webcast to Discuss Aclidinium Bromide Data Presentations at the American Thoracic Society Annual Congress
6. Vasogen to Webcast Presentation at the Rodman & Renshaw 5th Annual Global Healthcare Conference
7. Rosetta Genomics Announces Conference Call and Webcast of First Quarter Financial Results
8. TorreyPines Therapeutics to Host First Quarter 2008 Results Conference Call and Webcast
9. Quest Diagnostics Announces Annual Shareholders Meeting Webcast
10. Schering-Plough Schedules Webcast for Annual Meeting of Shareholders
11. Exelixis Announces May 13 Webcast of Presentation at the Bank of America Health Care Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/27/2014)... , Aug. 27, 2014 Tris Pharma, a ... technologies, today announced that it has been selected as ... Industry Association,s 2014 Awards for Excellence competition ... an independent panel of judges from SCORE (Counselors to ... winners will be honored at a gala event to ...
(Date:8/27/2014)... BIOEQUA, an innovative line of skin care ... handheld spray, has made its EQUA ESSENTIAL line available ... brand began with an unexpected discovery in an emergency ... that the application of nanospray technology allowed for liquid ... to skin's basal layer. This resulted in immediate absorption ...
(Date:8/27/2014)... White City, OR (PRWEB) August 27, 2014 ... Supply Report, “Consolidation continues to reshape the look and ... in nutrition. Consumer demand for higher-quality ingredients will push ... the North American market have experienced strong market growth ... and ethical attributes in their food and cosmetics to ...
(Date:8/27/2014)... WriteResult, LLC – a premier provider of ... superiority when it comes to meeting the needs of ... of their most recent study closeout on-time and with ... digital writing platform to collect Patient Reported Outcomes electronically ... drew data from a number of assessments including the ...
Breaking Biology Technology:Tris Pharma Selected as an award winner in the New Jersey Business & Industry Association's 2014 Awards for Excellence 2BIOEQUA'S EQUA ESSENTIAL Product Line Redefines Skin Care & Now Available in America 2Daring to be Different Raw Materials & Ingredient Supply Shortage Fuels Vital Force™ Technology New Ingredient Enhancements 2Daring to be Different Raw Materials & Ingredient Supply Shortage Fuels Vital Force™ Technology New Ingredient Enhancements 3A Perfect Record: WriteResult Maintains a 100% On-Time ePRO Record with Latest Irritable Bowel (IBS) Study Data Lock 2
... Barr,Pharmaceuticals, Inc. (NYSE: BRL ) today announced that ... U.S. Food & Drug,Administration (FDA) to manufacture and market ... hydrobromide extended release,capsules), eq. to 8 mg, 16 mg ... the,first company to file an Abbreviated New Drug Application ...
... Receives $1.1 Million to Investigate Innocence Claims, ... (DOJ) today announced over $1.1 million to the ... reviewing cases where DNA testing and,evidence may prove ... Justice,Programs (OJP), the funding is one of five ...
... ProSource 2.0 is a customized lab supply ordering system ... of every lab supply they currently order. ProSource then ... prices to ensure savings on every order. ProSource eliminates ... lab in your company to order from the same ...
Cached Biology Technology:Barr Receives Approval for Generic Version of Razadyne(R) ER Capsules 2Barr Receives Approval for Generic Version of Razadyne(R) ER Capsules 3Barr Receives Approval for Generic Version of Razadyne(R) ER Capsules 4Barr Receives Approval for Generic Version of Razadyne(R) ER Capsules 5Department of Justice Provides States With Funding for Testing in Postconviction Cases 2ProSource 2.0 Offers Value, Savings for Lab Supplies 2
(Date:8/27/2014)... belief that a deficiency in serotonin a chemical ... in depression. In the journal ACS Chemical Neuroscience ... make serotonin in their brains (and thus should have ... symptoms. , Donald Kuhn and colleagues at the ... University School of Medicine note that depression poses a ...
(Date:8/27/2014)... abandoned each year in U.S. waters and become what ... fish, crabs, and other species such as turtles. These ... watermen who depend on the resources--losses that are largely ... The report, published in the Marine Pollution Bulletin ... the derelict fish trap problem, and so-called "ghost fishing," ...
(Date:8/27/2014)... of studies have shown that excessive iron ... Parkinson,s disease. Previous studies from Chunyan Guo ... China have shown that baicalin prevented iron ... metal transporter 1 expression, and increased ferroportin ... rotenone-induced Parkinson,s disease rats. However, the relationship ...
Breaking Biology News(10 mins):New study throws into question long-held belief about depression 2NOAA's Marine Debris Program reports on the national issue of derelict fishing traps 2
... 9, 2013 With fierce competition and ... specialists need to increase efficiency continually. CRMATCH presents an ... for organisations keen to stay abreast of developments in ... grapple with ever-increasing amounts of complex data, and rise ...
... of American Societies for Experimental Biology (FASEB) is proud to ... Winning entries were unveiled on FASEB,s web site and ... of Health main campus. "The competition provides a glimpse into ... FASEB President Margaret K. Offermann, MD, PhD. "The winning images ...
... pieced together as an elaborate molecular jigsaw involving around 30 ... it is only made by certain bacteria. In the early ... allow its construction one that requires oxygen and one ... so-called anaerobic pathway, which is the more common pathway, that ...
Cached Biology News:Most Efficient Matching in Recruitment With CRMATCH and ELISE 2FASEB announces BioArt image and video competition winners 2
E2F2 protein...
Rabbit Anti-melatonin (different linkage) Polyclonal Antibody...
... to Cholesterol Oxidase Immunogen Cholesterol ... Cross-reacts with bacteria. Not yet tested in ... oxidases exist as both type I and ... bacterial pathogenesis. In addition, they are important ...
Phospho-PERK (Thr980) Antibody...
Biology Products: